BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 26265006)

  • 21. Monocytes Represent One Source of Bacterial Shielding from Antibiotics following Influenza Virus Infection.
    Fischer KJ; Yajjala VK; Bansal S; Bauer C; Chen R; Sun K
    J Immunol; 2019 Apr; 202(7):2027-2034. PubMed ID: 30745458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibodies mediate formation of neutrophil extracellular traps in the middle ear and facilitate secondary pneumococcal otitis media.
    Short KR; von Köckritz-Blickwede M; Langereis JD; Chew KY; Job ER; Armitage CW; Hatcher B; Fujihashi K; Reading PC; Hermans PW; Wijburg OL; Diavatopoulos DA
    Infect Immun; 2014 Jan; 82(1):364-70. PubMed ID: 24191297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coinfection with Streptococcus pneumoniae negatively modulates the size and composition of the ongoing influenza-specific CD8⁺ T cell response.
    Blevins LK; Wren JT; Holbrook BC; Hayward SL; Swords WE; Parks GD; Alexander-Miller MA
    J Immunol; 2014 Nov; 193(10):5076-87. PubMed ID: 25311807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammation as a Modulator of Host Susceptibility to Pulmonary Influenza, Pneumococcal, and Co-Infections.
    Aguilera ER; Lenz LL
    Front Immunol; 2020; 11():105. PubMed ID: 32117259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toll-like receptor 4 agonistic antibody promotes innate immunity against severe pneumonia induced by coinfection with influenza virus and Streptococcus pneumoniae.
    Tanaka A; Nakamura S; Seki M; Fukudome K; Iwanaga N; Imamura Y; Miyazaki T; Izumikawa K; Kakeya H; Yanagihara K; Kohno S
    Clin Vaccine Immunol; 2013 Jul; 20(7):977-85. PubMed ID: 23637040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-22 reduces lung inflammation during influenza A virus infection and protects against secondary bacterial infection.
    Ivanov S; Renneson J; Fontaine J; Barthelemy A; Paget C; Fernandez EM; Blanc F; De Trez C; Van Maele L; Dumoutier L; Huerre MR; Eberl G; Si-Tahar M; Gosset P; Renauld JC; Sirard JC; Faveeuw C; Trottein F
    J Virol; 2013 Jun; 87(12):6911-24. PubMed ID: 23596287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toll-Like Receptor 3/TRIF-Dependent IL-12p70 Secretion Mediated by Streptococcus pneumoniae RNA and Its Priming by Influenza A Virus Coinfection in Human Dendritic Cells.
    Spelmink L; Sender V; Hentrich K; Kuri T; Plant L; Henriques-Normark B
    mBio; 2016 Mar; 7(2):e00168-16. PubMed ID: 26956584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aspirin-triggered resolvin D1 reduces pneumococcal lung infection and inflammation in a viral and bacterial coinfection pneumonia model.
    Wang H; Anthony D; Yatmaz S; Wijburg O; Satzke C; Levy B; Vlahos R; Bozinovski S
    Clin Sci (Lond); 2017 Sep; 131(18):2347-2362. PubMed ID: 28779028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-4 protects mice against lethal influenza and Streptococcus pneumoniae co-infected pneumonia.
    Peng Y; Wang X; Wang H; Xu W; Wu K; Go X; Yin Y; Zhang X
    Clin Exp Immunol; 2021 Sep; 205(3):379-390. PubMed ID: 34061992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CCR2+ monocyte-derived dendritic cells and exudate macrophages produce influenza-induced pulmonary immune pathology and mortality.
    Lin KL; Suzuki Y; Nakano H; Ramsburg E; Gunn MD
    J Immunol; 2008 Feb; 180(4):2562-72. PubMed ID: 18250467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Type I Interferon Signaling Is a Common Factor Driving Streptococcus pneumoniae and Influenza A Virus Shedding and Transmission.
    Zangari T; Ortigoza MB; Lokken-Toyli KL; Weiser JN
    mBio; 2021 Feb; 12(1):. PubMed ID: 33593970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TNF-related apoptosis-inducing ligand (TRAIL) exerts therapeutic efficacy for the treatment of pneumococcal pneumonia in mice.
    Steinwede K; Henken S; Bohling J; Maus R; Ueberberg B; Brumshagen C; Brincks EL; Griffith TS; Welte T; Maus UA
    J Exp Med; 2012 Oct; 209(11):1937-52. PubMed ID: 23071253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Murine Model for Enhancement of Streptococcus pneumoniae Pathogenicity upon Viral Infection and Advanced Age.
    Joma BH; Siwapornchai N; Vanguri VK; Shrestha A; Roggensack SE; Davidson BA; Tai AK; Hakansson AP; Meydani SN; Leong JM; Bou Ghanem EN
    Infect Immun; 2021 Jul; 89(8):e0047120. PubMed ID: 34031128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Vitamin A Deficiency in Dysregulating Immune Responses to Influenza Virus and Increasing Mortality Rates After Bacterial Coinfections.
    Penkert RR; Smith AP; Hrincius ER; McCullers JA; Vogel P; Smith AM; Hurwitz JL
    J Infect Dis; 2021 May; 223(10):1806-1816. PubMed ID: 32959872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influenza "Trains" the Host for Enhanced Susceptibility to Secondary Bacterial Infection.
    Shirey KA; Perkins DJ; Lai W; Zhang W; Fernando LR; Gusovsky F; Blanco JCG; Vogel SN
    mBio; 2019 May; 10(3):. PubMed ID: 31064834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of intravenous peramivir, compared with oral oseltamivir, on the outcome of post-influenza pneumococcal pneumonia in mice.
    Tanaka A; Nakamura S; Seki M; Iwanaga N; Kajihara T; Kitano M; Homma T; Kurihara S; Imamura Y; Miyazaki T; Izumikawa K; Kakeya H; Yanagihara K; Kohno S
    Antivir Ther; 2015; 20(1):11-9. PubMed ID: 24517996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Marked improvement of severe lung immunopathology by influenza-associated pneumococcal superinfection requires the control of both bacterial replication and host immune responses.
    Damjanovic D; Lai R; Jeyanathan M; Hogaboam CM; Xing Z
    Am J Pathol; 2013 Sep; 183(3):868-80. PubMed ID: 23831294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogenic potential of interferon αβ in acute influenza infection.
    Davidson S; Crotta S; McCabe TM; Wack A
    Nat Commun; 2014 May; 5():3864. PubMed ID: 24844667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tpl2 Ablation Leads to Hypercytokinemia and Excessive Cellular Infiltration to the Lungs During Late Stages of Influenza Infection.
    Latha K; Jamison KF; Watford WT
    Front Immunol; 2021; 12():738490. PubMed ID: 34691044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Memory Th17 cell-mediated protection against lethal secondary pneumococcal pneumonia following influenza infection.
    Li Y; Yang Y; Chen D; Wang Y; Zhang X; Li W; Chen S; Wong SM; Shen M; Akerley BJ; Shen H
    mBio; 2023 Aug; 14(4):e0051923. PubMed ID: 37222516
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.